Company Search:
Advanced Search
Sponsored Links
Arcoma AB Company Snapshot
Arcoma AB operates within the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arcoma AB with three other companies in this sector in SWEDEN : C-Rad AB (2019 sales of 205.40 million Swedish Kronor [US$20.30 million] ), Ortivus AB (50.85 million Swedish Kronor [US$5.03 million] ), and Cellink AB (105.46 million Swedish Kronor [US$10.42 million] ).

Sales Analysis. During the year ended December of 2019, sales at Arcoma AB were SEK 133.75 million (US$13.22 million). This is an increase of 12.0% versus 2018, when the company's sales were SEK 119.47 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Arcoma AB had sales of SEK 130.43 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Arcoma AB
  Stock Performance Chart for Arcoma AB
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 14.55
(Figures in Swedish Kronor)
1 Week 1.7%   13 Weeks -18.3%  
4 Weeks -29.0%   52 Weeks -25.0%  
Arcoma AB Key Data:
  Ticker: ARCOMA Country: Sweden
  Exchanges: STO Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2019 Sales 133,754,000
(Year Ending Jan 2020).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 183,978,537
  Fiscal Yr Ends: December Shares Outstanding: 12,644,573
  Share Type: Ordinary Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.